Table 4.
# | Age at diagnosis(months) | BM infiltration(% NB cells) | Stage | MYCN status | Relapse | Time of relapse(months) | Follow-up | Time of follow-up(months) |
---|---|---|---|---|---|---|---|---|
1 | 42 | <10 | M | gain | yes | 5.3 | alive | 45.2 |
2 | 72 | <10 | M | single copy | no | alive | 49.8 | |
3 | 1 | <10 | Ms | single copy | no | alive | 42.2 | |
4 | 46 | <10 | M | single copy | yes | 27.4 | alive | 34.9 |
5 | 21 | <10 | M | amplified | no | alive | 56.9 | |
6 | 20 | >10 | M | amplified | no | alive | 59.4 | |
7 | 36 | >10 | M | single copy | yes | 24.7 | dead | 48.8 |
8 | 17 | >10 | M | amplified | yes | 11.4 | dead | 18.1 |
9 | 9 | <10 | M | single copy | no | alive | 34.5 | |
10 | 26 | <10 | M | gain | no | alive | 46.0 | |
11 | 3 | <10 | Ms | amplified | N.A. | N.A. | ||
12 | 52 | >10 | M | amplified | N.A. | N.A. | ||
13 | 32 | <10 | M | - | N.A. | N.A. | ||
14 | 2 | >10 | L2 | single copy | N.A. | N.A. | ||
15 | 46 | >10 | L2 | single copy | N.A. | N.A. | ||
16 | 11 | >10 | M | single copy | N.A. | N.A. | ||
17 | 39 | <10 | M | - | N.A. | N.A. | ||
18 | 18 | <10 | L2 | single copy | N.A. | N.A. | ||
19 | 4 | >10 | Ms | single copy | N.A. | N.A. | ||
20 | 8 | <10 | Ms | gain | N.A. | N.A. | ||
21 | 39 | <10 | L2 | - | N.A. | N.A. | ||
22 | 16 | >10 | M | single copy | N.A. | N.A. | ||
23 | 140 | >10 | M | single copy | N.A. | N.A. | ||
24 | 4 | >10 | M | single copy | N.A. | N.A. | ||
25 | 53 | <10 | M | single copy | N.A. | N.A. | ||
26 | 34 | <10 | L | single copy | N.A. | N.A. | ||
27 | 140 | <10 | M | - | N.A. | N.A. |